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Abstract 
Maxillectomy is the surgical removal or resection of the maxilla or upper jaw bone. A total or partial 
maxillectomy can be performed depending on how far the tumour has spread. This paper will discuss a 
patient diagnosed with an aggressive tumour in half of the top jaw who had to undergo an operation to 
remove the hemi-maxilla and orbital floor. Due to the extent and complexity of the defect, it was decided 
to manufacture an anatomical model of the hard tissues for planning a possible laser-sintered titanium 
implant using Additive Manufacturing (AM).  The CRPM had only two weeks to design and manufacture 
the titanium implant, due to the severity of the tumour. The anatomical model was sent to the surgeon to 
cut the nylon model where the bone resection was planned. Furthermore, the prosthodontist made a wax 
model of the planned titanium frame that was reverse- engineered and used as reference geometry in 
the design software.Materialise® design suite was used to design the patient-specific maxilla and cutting 
jig. The EOS M280 Direct Metal Laser Sintering (DMLS) system was instrumental in achieving the direct 
manufacturing of the bio-compatible titanium implant. The EOS P385 system was used to manufacture 
the pre-operation planning model as well as the cutting jig.The process chain followed to complete this 
case study will be discussed showing how this intervention improved the quality of life of a SA patient. 
Furthermore, the proposed paper and presentation will discuss the post-operation review of the patient 
showing the impact AM had in accelerating patient-specific implant manufacturing. The authors seek to 
claim a progressed level of maturity in the proposed manufacturing value chain. The claim is based on 
the successful completion of the analysis and synthesis of the problem , the validated proof-of-concept of 
the manufacturing process and the in-vivo implementation of the final product. 
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1 INTRODUCTION 
Amelobastomas are rare, benign tumours of 
odontogenic origin. They are slow-growing, locally 
invasive, and commonly affect the posterior maxilla 
and mandible. These tumours were first described 
by Cusack in 1827 [1]. They are the most common 
odontogenic tumours in Africa, and the second most 
common odontogenic tumours in the United States 
[2-5]. The global incidence of these has been 
estimated to be 0.5 cases per million people per 
year, with their peak incidence occurring between 
30-60 years of age [6]. They most often present as a 
painless swelling of the jaw [7], with up to 35% 
identified incidentally on radiographs [8]. Pain can 
be present if there is bleeding following fine needle 
aspiration [9]. Paraesthesia, tooth resorption, and 
tooth displacement are uncommon findings with 
these tumours [10]. These tumours have a 
predilection for occurring in the posterior regions of 
the jaws, with the mandible accounting for up to 
80% of all cases [11]. 
Maxillectomy or maxillary resection is defined as 
surgical removal of a part, or all of the maxilla [13]. 
The maxilla’s central location in the facial skeleton 
unifies the orbits, zygomatic maxillary complex, 
nose, and stomatognathic complex into a functional 
and aesthetic unit [14]. The maxilla provides the 
structural support connecting the skull base to the 
occlusal plane, resists the forces of mastication, 
anchors the maxillary dentition, provides a 
separation between the oral and nasal cavities, 
forms the floor of the orbit supporting the globe, and 
supports the facial musculature. The bony and soft 
tissues constituting the midface are supported by 
the maxilla and provide much of the facial contour 
and profile giving each person a unique appearance 
[15–17]. 
Reconstruction of maxillectomy defects remains a 
considerable challenge because the 3-dimensional 
architecture of the midface serves both functional 
and aesthetic roles. Based on these considerations, 
the final goals for midface reconstruction should 
ideally be [18]: 
(1) to give support to the orbital content, thus 
minimizing  changes in globe position, orbital 
volume, eyelid functions and treat the exenterated 
orbit cosmetically;  
(2) to maintain a patent nasal airway and oronasal 
separation creating sufficient platform for 
mastication, speech quality, and potential dental 
rehabilitation; and  
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(3) to restore an adequate and symmetric facial 
contour with the other side of the face.  
Additive manufacturing (AM), or better known as 3D 
printing (3DP), describes a number of processes 
where a product is fabricated through a layer-wise 
construction method. The Direct Metal Laser 
Sintering (DMLS) AM process at the Centre for 
Rapid Prototyping and Manufacturing (CRPM) can 
offer a unique solution for the manufacturing of 
custom-designed maxillofacial implants, using Ti64 
(Ti6Al4V). 
Vandenbroucke & Kruth (2007) continue to state 
that because of technical improvements of layer 
manufacturing (LM) processes and the possibility to 
process different metals (and compounds), Rapid 
Prototyping (RP) has moved beyond its initial 
applications into rapid manufacturing (RM). They 
also point out that the progress made could benefit 
medical and dental applications beyond polymer 
applications for visual (anatomical) models or single-
use surgical guides, to also support the 
manufacturing of functional implants or prostheses. 
This paper presents factual evidence that the 
process chain based on customized manufacturing 
has evolved to a level of maturity which can be 
replicated with confidence.  
 
2 CASE PRESENTATION 
2.1 Clinical report 
A 54-year old female patient was referred to the 
surgical team for a resection of a tumour in her left 
maxilla. Clinical and radiographic findings revealed 
that the tumour filled the entire left maxillary sinus, 
and measured 60x50x40mm in size. 
2.2 CT conversion 
Due to the extent and complexity of the defect, it 
was decided to fabricate an anatomical model of the 
hard tissues for planning a possible fabrication of a 
Ti6Al4V laser-sintered frame for the patient. 
Computer Tomography (CT) was used as a starting 
platform and the Digital Imaging and 
Communications in Medicine (DICOM) files from the 
scanner were converted to Standard Triangulation 
Language (STL) format (Figure 1) using Mimics™ 
dedicated software from Materialise®. The software 
allows altering the greyscale values from the 
DICOM images to differentiate between soft tissue 
and bone. 
 
Figure 1 - CT conversion to STL format 
2.3 AM of pre-operative model 
The region of interest was then masked and 
calculated as a 3D model, which was exported as a 
STL file, sliced using RP Tools, and sent to the AM 
machine to manufacture the planning model. The 
CRPM did the CT segmentation of the skull and 
produced the 3D model in an EOS P385 Laser 
Sintering machine in PA 2200 polyamide material at 
150 µm layer thickness (Figure 2). 
 
Figure 2 - Skull replica manufactured using 
Additive Manufacturing in PA 2200 
polyamide material 
The treatment plan involved a complete resection of 
the tumour with simultaneous reconstruction using a 
custom-made titanium framework to replace the 
resected bone. The nylon model was sent to the 
surgical team to be cut where the bone resection 
was planned (Figure 3) 
 
Figure 3 - Nylon model cut where the bone 
resection was planned 
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2.4 Reverse engineering and design of 
titanium implant 
The CRPM had only two weeks to design and 
manufacture the Ti6Al4V implant, due to the severity 
of the tumour. Furthermore, the prosthodontist made 
a wax model of the planned titanium frame (Figure 
4). 
 
Figure 4 - Wax model of the planned titanium 
frame 
The wax model and skull were reverse-engineered 
using a Minolta 3D camera and Geomagic® 
software (Figure 5). The reverse-engineered 
geometry was used to identify the boundaries and 
fixation areas of the planned implant. 
 
Figure 5 - Reverse engineering data in 
Geomagic® software 
The 3D data were imported into 3-MATIC® (from 
Materialise) in order to design the implant (Figure 6). 
 
Figure 6 - Implant design done on 3-MATIC® 
 
3 AM OF BIO-COMPATIBLE TITANIUM 
IMPLANT 
3.1 DMLS 
The implant design was exported as an STL file, 
which was converted to a slice file and transferred to 
an EOS M280 DMLS machine. The implant was 
manufactured from a biocompatible Ti6Al4V (ELI) 
powder of sub-40 µm particle size (Figure 7).  
 
Figure 7 - DMLS implant in Ti6Al4V 
The DMLS implant was removed from the titanium 
substrate. The support structures were removed and 
the implant was manually polished. The implant’s 
fitment was checked on the pre-operative model 
(Figure 8). 
 
Figure 8 - Checking the implant’s fitment on the               
pre-operative model 
A cutting guide (Figure 9) was designed and 
manufactured in nylon on the EOS P385 machine.  
The surgeons used this guide to remove the 
affected bone at the correct angles. 
 
Figure 9 - AM nylon cutting guide 
The DMLS titanium prosthesis was successfully 
implanted during a nine-hour operation (Figure 10). 
The patient was transferred to the Intensive Care 
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Unit and a week later to a general ward. The post-
operative review was good and many valuable 
lessons were learned from this case study.  
 
Figure 10 - DMLS Ti6Al4V prosthesis in position  
The swelling, as shown in Figure 11, was due to the 
soft tissue harvested from the patient’s forearm and 
transplanted into the oral cavity. This soft tissue was 
implanted to create a separation between the oral 
and nasal cavities. 
 
Figure 11 - Post-operative review one month after 
the operation 
3.1.1 Timeline for design and AM of maxilla 
The CRPM only had fourteen days from receiving 
the patient data to the operation due to the severity 
of the tumour. The process steps are shown below:  
 
• CT translation, pre-operative model – 2 days 
• Surgical planning & wax mock-up – 1 day 
• Reverse engineering – 3 hours 
• Final design – 3 days 
o Design time – 19 hours (implant 
and surgical guide) 
o The remainder of the 3 days was for 
consultation and approval 
• Manufacturing – 2 days (including support 
removal and stress relieving) 
o DMLS – 18 hours 
• Polishing – 2 days 
• Micro CT scanning – 1 day 
• Heat treatment – 1 day 
• Cleaning and packaging – 2 days 
• Operation –  9 hours 
Compared to: 
Conventional manufacturing – 5 weeks 
      or 
Additive manufacturing overseas at a cost of 
$17000  - 4 weeks 
3.2 Challenges encountered with DMLS 
implant manufacturing 
Figure 12 shows a summary of a proposed workflow 
which must be adhered to for certification of the 
DMLS process 
 
 
Figure 12 - The proposed AM of titanium implants 
workflow (author’s own creation) 
The DMLS process uses a cold bed platform which 
induces high residual stress in the manufactured 
part. The parts need to be stress-relieved at 650°C 
in an argon atmosphere while still fixed on the 
titanium substrate. Initial research showed that 
between 76 to 81% of the residual stress can be 
removed with this stress-relieving cycle [12]. In this 
study, the researchers used recrystallizing, duplex 
and beta-annealing processes to further remove the 
residual stress to levels up to 97%. As-grown the 
parts are still too brittle for medical use and need to 
be heat-treated at 1000°C to increase the 
elongation to above 10%, as required for medical 
implants. Further in-depth research needs to be 
conducted to fully quantify residual stresses, as well 
as optimise stress-relieving and heat-treatment 
cycles. In the current practice, the part integrity is 
tested by scanning all the implants using X-ray 
micro- computer tomography (microCT). For this, a 
commercial system from the Central Analytical 
Facilities at Stellenbosch University (SU), a General 
Electric Phoenix V|Tome|X L240, is used. X-ray 
settings are 180 kV and 160 μA, using a directional 
X-ray source. This is done to detect any microscopic 
voids and cracks that could cause implant failure 
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due to fatigue. The surface fit function allows for a 
good 3D visualization, as shown in Figure 13.  
 
Figure 13 - Post-operative review one month after 
the operation 
The part showed no voids, but loose powder was 
seen inside the blind hole (Figure 14). 
 
Figure 14 - Powder trapped inside blind hole 
Furthermore, test pieces for destructive testing 
(Figure 15) are manufactured on the same platform 
as the implants and are tested in an as-grown and 
heat-treated state. Results are shown in Table 1. 
 
Figure 15 - Test pieces for destructive mechanical 
testing 
Description UTS 
(MPa) 
Elongation 
(%) 
As grown Mean of 3 specimens 
1155 4.12 
After heat 
treatment 
Mean of 3 
specimens 
850.30 11.88 
Table 1 - Tensile test results 
 
4 CONCLUSIONS 
 It was possible to successfully complete this 
extremely difficult case study in only two weeks. 
Considering the timeframes given by the surgeons, 
it would have been difficult to manufacture the 
implant using conventional manufacturing 
techniques. The wax mock-up made of the cutting 
guide on the pre-operative model by the 
prosthodontist saved around 10 hours in design 
time. The part integrity proved to be good as the 
microCT scan showed no voids or cracks inside the 
implant. The microCT scan was done at 85µm 
slices.The heat treatment increased the ductility 
from 4% (as grown) to above 10%, which is required 
for implants.  
This case study shows that AM can be successfully 
used in the manufacturing of patient-specific 
implants. Similarly previous cases by the same team 
have developed the process chain into a value chain 
of progressed maturity level. Process parameters 
are now known and parameter boundaries are set to 
ensure confidence in quality consistancy. 100% 
inspection of part integrity by microCT is retained to 
build out the knowledge database and confidence.  
Adequate confidence has now been demonstrated 
that the value chain can be further optimized and 
predictive models on cost and time applied. Several 
unpublished design for manufacturing safeguards 
are still employed, that may become unnecessary 
as DMLS technology continuously improves. The 
presented value chain can therefore be agrued 
progressively matured by the complexity of the case 
study. 
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